Press Release: Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B ...
Sanofi to acquire Dren Bio’s bispecific myeloid cell engager for deep B-cell depletion, broadening immunology pipelineDren Bio deep B-cell ...
Pharmabiz10 天
Sanofi to pay $600 million upfront payment to buy Dren Bio's bispecific myeloid cell ...
Sanofi to pay $600 million upfront payment to buy Dren Bio's bispecific myeloid cell engager, DR-0201: Paris Friday, March 21, 2025, 09:00 Hrs [IST] Sanofi and Dren Bio, Inc., a p ...